> TRANSFORMATIVE POSSIBILITIES _
Healthcare Research & Analytics
Using discipline, collaboration and human imagination to define and measure client commercialization opportunities
Innovation drives our pursuit of improvement, as we are inspired by the advancements of science in #pharmaceuticals, #biotech, #biologics, #genetics, #meddevices, #specialtydrugs and #medtech
We are on a mission to uncover truths, novel insights and new perspectives for our healthcare partners in the life sciences.
In this endeavor we employ human ingenuity in hand with advanced analytic methods, science-based and cutting-edge tools (e.g., AI/ML/LLMs), all in our effort to discover new answers and understandings.
Our aim is to push the boundaries of healthcare research as we gather insights, transforming the standards and delivering operational excellence through innovation.
Everything we do is driven by the aspiration and advancement of improvement.
Therapeutic expertise from biologics to diabetes, medical devices to oncology, covering the full spectrum of healthcare today and tomorrow (immune therapies, medtech, digital therapeutics)
MEDICAL TECHNOLOGY
Surgery using sonic beam technology
Histotripsy is the delivery of acoustic energy using high intensity sonic beam pulses via focused ultrasound, causing ablation by controlling micro bubbles. This new technique could revolutionize select surgeries as it provides a non-invasive means of cutting without any external incision. It could reduce tumors in many types of cancers, reduce fibroids and make incisions via ultrasound while the operator views results in real-time.
ONCOLOGY
Non-invasive liquid biopsies in oncology
The use of liquid biopsies in oncology care has provided a breakthrough by introducing a non-invasive detector and monitor for tumors and mutations, measuring circulating epithelial cells (tumor cells) in whole blood. This technology is used for enumeration and phenotyping in patients with metastatic breast, colorectal and prostate cancer, and wider use is on the way.
ALZHEIMER’S
New clues in the genetics of Alzheimer’s
Similar to other major diseases Alzheimer’s Disease (AD) is a complex illness with multifactorial underlying potential causes, but scientists studying the connection between genetic markers and AD recently found 75 independent potential factors including 42 brand-new signals which were not previously known to be connected. The future may provide the development of gene-specific treatments and personalized medications to avoid the development of AD.
A commitment to excellence, bringing passion and dedication to the work we do; taking pride in helping our clients make better decisions in healthcare.
AFRICA HEALTHCARE MARKET PRESENTS UNIQUE CHALLENGES
As a pharmaceutical market Africa is highly fragmented, without the large wholesale channels that exist in other areas of the world. Small pharmacies make up the largest share of the retail market in Africa. The ten largest retail pharmacy chains in Nigeria, Kenya and Ghana have fewer than 200 locations in total.
THE FUTURE OF INSULIN TRACKING IS BLOOD-FREE
While new and improved diabetes therapies continue to be developed by the pharmaceutical industry, technology companies are also introducing non-invasive glucose monitoring devices which could mean an end to the seemingly-never-ending “sticks” well-known to patients suffering from diabetes.
SIMPLE BLOOD TEST FOR CANCER DETECTION
While specific cancer screening is not new, there is an exciting early detection tool now available called the Galleri Test which uses next-generation DNA sequencing and machine learning to recognize the early stages of 50 different cancers well before there are any visible symptoms.
WHY IS COLORECTAL CANCER RISING IN THE YOUNG?
Colorectal cancer (CRC) is relatively rare but there is an alarming trend of diagnosed cases among those under age 50 worldwide, leaving healthcare professionals and researchers wondering why given that the data show decreases in CRC in older age groups.